EC HEALTHCARE (02138) announces its interim results. The loss attributable to equity shareholders was HK$10.312 million, a change from profit to loss compared to the same period last year.

EC HEALTHCARE (02138) announced its interim results for the six months ending September 30, 2025. The total revenue was approximately HKD 1.931 billion, a decrease of 6.4% compared to the same period last year. The company's net loss attributable to equity shareholders was HKD 10.312 million, a profit to loss year-on-year conversion. The loss per share was 0.9 HK cents. The announcement stated that the decrease in profitability was mainly due to a reduction in revenue and sales volume, leading to a decrease in operating leverage in various key business segments. The shift in service mix to lower profit categories, as well as the income from the sale of medical assets in the same period last year which did not contribute to profit, further dragged down the group's profitability.